Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants
Clinical trial NCT05635110 · COMPLETED
Trial details
- NCT number
- NCT05635110
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2023-06-08
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.